Cosmos Health Inc COSM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Cosmos Health to Resume Share Repurchases as Insiders Commit to 12-Month Lock-Up
Cosmos Health Reports Record Nine-Month Revenue of $53.6 Million, Up 18%; Q3 Gross Margin Up 465 Basis Points Sequentially; Total Debt Down 34% and Stockholders' Equity Up 21% Since Year-End
Cosmos Health Provides U.S. E-Commerce Update for October 2026: Monthly Subscription Value Reaches $1.83 Million, Approximately $22 Million Annualized
Cosmos Health's CosmoFarm Begins Commissioning New Automated Order-Processing and Vehicle-Loading Infrastructure, Advancing Capacity That Could Support Over $120 Million in Annual Revenue
Cosmos Health's Amazon UK Business Surpasses $2 Million in TTM Sales, Up 90%, with a 23% Net Profit Margin; Expects Sales to Grow Approximately 72% to $3.9 Million Over the Next Twelve Months
Cosmos Health's U.S. Active Subscriptions Surpass 12,000, Up 92% in Two Weeks
Noble Capital Markets Initiates Equity Research Coverage on Cosmos Health with Outperform Rating and $1.40 Price Target
Cosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already Underway
Trading Information
- Previous Close Price
- $2.87
- Day Range
- $2.55–3.26
- 52-Week Range
- $2.20–14.37
- Bid/Ask
- $2.76 / $3.20
- Shares Outstanding
- 5.03M
- Market Cap
- $14.14M
- Volume/Avg
- 141,346 / 163,680
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.08
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 163
Valuation
Metric | COSM |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.55 |
Price/Sales | 0.08 |
Price/Cash Flow | — |
Price/Earnings
COSM
Financial Strength
Metric | COSM |
|---|---|
Quick Ratio | 0.68 |
Current Ratio | 1.05 |
Interest Coverage | −5.67 |
Quick Ratio
COSM
Profitability
Metric | COSM |
|---|---|
Return on Assets (Normalized) | −11.13% |
Return on Equity (Normalized) | −32.96% |
Return on Invested Capital (Normalized) | −9.40% |
Return on Assets
COSM
Medical Distribution Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| McKesson Corp MCK | LOCK|$q%^%!$ | LOCK|glntX | $123B | |||
| Cencora Inc COR | LOCK|%wrQ&@ | LOCK|S&<P> | $65B | |||
| Cardinal Health Inc CAH | LOCK|x!Wfj!@ | LOCK|Z>!G | $63B | |||
| Sigma Healthcare Ltd SIGGF | — | LOCK|<N#s> | $22B | |||
| Henry Schein Inc HSIC | LOCK|DN>bVJ | LOCK|>!N# | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR SHPMY | — | LOCK|#L | $8B | |||
| Sinopharm Group Co Ltd SHTDF | — | LOCK|SZr | $7B | |||
| Sinopharm Group Co Ltd ADR SHTDY | — | LOCK|qfg | $7B | |||
| Galenica Ltd GALNF | — | LOCK|JNN | $5B | |||
| Medipal Holdings Corp MEPDF | — | LOCK|^N | $4B |